PTPA and colorectal carcinoma: In the current study, we demonstrate that the loss of PP2A function through genetic manipulation or drug treatment makes a variety of mouse immune tolerance tumour models sensitive to ICB, and it has been further confirmed by using human cancer cell lines and human CRC tissue arrays.